rs2311045
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_031475.3(ESPN):c.909C>G(p.Arg303=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 1,606,166 control chromosomes in the GnomAD database, including 15,663 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2335 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13328 hom. )
Consequence
ESPN
NM_031475.3 synonymous
NM_031475.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.998
Genes affected
ESPN (HGNC:13281): (espin) This gene encodes a multifunctional actin-bundling protein. It plays a major role in regulating the organization, dimensions, dynamics, and signaling capacities of the actin filament-rich, microvillus-type specializations that mediate sensory transduction in various mechanosensory and chemosensory cells. Mutations in this gene are associated with autosomal recessive neurosensory deafness, and autosomal dominant sensorineural deafness without vestibular involvement. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
?
Variant 1-6440984-C-G is Benign according to our data. Variant chr1-6440984-C-G is described in ClinVar as [Benign]. Clinvar id is 226636.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-6440984-C-G is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=-0.998 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ESPN | NM_031475.3 | c.909C>G | p.Arg303= | synonymous_variant | 5/13 | ENST00000645284.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ESPN | ENST00000645284.1 | c.909C>G | p.Arg303= | synonymous_variant | 5/13 | NM_031475.3 | P1 | ||
ESPN | ENST00000636330.1 | c.909C>G | p.Arg303= | synonymous_variant | 5/11 | 5 | |||
ESPN | ENST00000418286.1 | c.264C>G | p.Arg88= | synonymous_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.165 AC: 25015AN: 152018Hom.: 2331 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
25015
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.136 AC: 31699AN: 232850Hom.: 2344 AF XY: 0.138 AC XY: 17556AN XY: 127514
GnomAD3 exomes
AF:
AC:
31699
AN:
232850
Hom.:
AF XY:
AC XY:
17556
AN XY:
127514
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.132 AC: 191864AN: 1454030Hom.: 13328 Cov.: 37 AF XY: 0.133 AC XY: 96018AN XY: 722742
GnomAD4 exome
AF:
AC:
191864
AN:
1454030
Hom.:
Cov.:
37
AF XY:
AC XY:
96018
AN XY:
722742
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.165 AC: 25041AN: 152136Hom.: 2335 Cov.: 32 AF XY: 0.164 AC XY: 12193AN XY: 74370
GnomAD4 genome
?
AF:
AC:
25041
AN:
152136
Hom.:
Cov.:
32
AF XY:
AC XY:
12193
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
570
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 20, 2015 | p.Arg303Arg in exon 5 of EPSN: This variant is not expected to have clinical sig nificance because it has high frequency in the general population, does not alte r an amino acid residue and is not located within the splice consensus sequence. It has been identified in 19.5% (14152/72600) of all chromosomes by the Exome A ggregation Consortium (ExAC, http://exac.broadinstitute.org;dbSNP rs2311045). - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at